Burotto M, Zvirbule Z, Alvarez R, Chewaskulyong B, et al. Brief Report: Updated Data From IMscin001 Part 2, a Randomized Phase III Study of Subcutaneous Versus Intravenous Atezolizumab in Patients With Locally Advanced or Metastatic NSCLC. J Thorac Oncol 2024;19:1460-1466.
PMID: 38729426